Prasugrel Tablets

Vildagliptin Tablet

Therapeutic Indication

Acute Coronary Syndrome (ACS)
Prevention of thrombotic cardiovascular events
Patients undergoing PCI (angioplasty with stent placement)
+91 85919 78885

Prasugrel

Tablet

Prasugrel is an antiplatelet agent that works by inhibiting platelet activation and aggregation. It is prescribed to reduce the risk of heart attack, stroke, and other cardiovascular complications in patients with ACS undergoing PCI.

Speciality Cardiology | Internal Medicine
Tags Antiplatelet | Cardiovascular
Strength
  • 10 mg
Packing Size
  • 10 Tablets

Check all Tablets Range

Click to know More

Mechanism

Prasugrel is a thienopyridine class antiplatelet agent. It irreversibly inhibits the P2Y12 ADP receptor on platelets, preventing activation and aggregation, thereby reducing clot formation.

Pharmacokinetics

  • Absorption: Rapidly absorbed after oral administration
  • Metabolism: Hepatic metabolism to active metabolite
  • Elimination: Renal and fecal pathways
  • Half-life: Approximately 7 hours

Side Effects

  • Bleeding (including gastrointestinal and intracranial)
  • Hypertension
  • Headache
  • Dizziness

Contraindication

  • Active pathological bleeding
  • History of stroke or transient ischemic attack (TIA)
  • Hypersensitivity to Prasugrel

Interaction

  • Other anticoagulants (increased bleeding risk)
  • NSAIDs
  • SSRIs/SNRIs

Warning and Precautions

  • Use with caution in elderly patients (≥75 years)
  • Discontinue if severe bleeding occurs
  • Not recommended for patients with low body weight (<60 kg)

Dosage

As directed by the Physician.